Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FET-PET-Guided Management of Pseudoprogression in Glioblastoma

NCT06480721 is registered in ClinicalTrials.gov with Veerle Ruijters as lead sponsor.

NCT NCT06480721
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06480721 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FET-PET-Guided Management of Pseudoprogression in Glioblastoma
Lead sponsor
Veerle Ruijters
Phase
Not applicable
Overall status
Not yet recruiting
Start date
August 31, 2024
Completion date
December 31, 2027
Enrollment
144 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma, radionecrosis of brain